Why is glioblastoma so deadly? DelMar discusses the need for new cancer research and treatments for Brain Tumor Awareness Month May 1, 2014 • 8:00 AM EDT
DelMar Pharmaceuticals VAL-083 Clinical Trial in GBM Demonstrates Continued and Promising Progress at AACR April 9, 2014 • 11:00 AM EDT
DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer April 7, 2014 • 10:30 AM EDT
DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting April 2, 2014 • 1:20 PM EDT
DelMar Pharmaceuticals Gives Quarterly Shareholder Update and Announces Investor Conference Call March 20, 2014 • 8:00 AM EDT
DelMar Pharmaceuticals to Present at the 26th Annual ROTH Capital Conference March 4, 2014 • 8:00 AM EST
DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial February 26, 2014 • 8:00 AM EST
DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com December 9, 2013 • 8:00 AM EST
DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com December 5th December 2, 2013 • 4:11 PM EST
DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting November 22, 2013 • 8:00 AM EST